Belvedere Trading’s Prothena Corp PRTA Stock Holding History

Belvedere Trading’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,584	Closed	-$366K	–	409
2021 Q1	$366K	Buy	+14,584	New	+$274K	0.03%	118

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Belvedere Trading's PRTA Position: Q2 2021 in Review

Belvedere Trading sold out of Prothena Corp (PRTA) in Q2 2021, closing a stake of 14,584 shares — an estimated $366K sold.

Belvedere Trading first reported a position in PRTA in Q1 2021 and held it in 1 quarter. The position peaked at $366K in Q1 2021. 156 funds tracked by Wall St. Rank hold PRTA as of Q2 2021.

Belvedere Trading reported no remaining Prothena Corp position as of Q2 2021 after selling out during the quarter.
Belvedere Trading sold 14,584 Prothena Corp shares in Q2 2021, an estimated $366K.
Belvedere Trading first reported a position in Prothena Corp in Q1 2021 and held it in 1 quarter.
Belvedere Trading's Prothena Corp position peaked at $366K in Q1 2021.
156 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2021.

Based on Belvedere Trading's 13F filing for Q2 2021, filed 23 Jul 2021.